Publication Name	World Journal of Meta-Analysis
Manuscript ID	80996
Country	United States

Received	2022-10-20 20:09
Peer-Review Started	2022-10-20 20:11
To Make the First Decision
Return for Revision	2022-11-16 22:04
Revised	2022-11-30 14:46
Second Decision	2023-01-13 03:35
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2023-01-17 17:59
Articles in Press	2023-01-17 17:59
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2023-01-30 07:18
Publish the Manuscript Online	2023-02-02 09:33

ISSN	2308-3840 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Minireviews
Article Title	Treatment of recurrent hepatocellular carcinoma following liver resection, ablation or liver transplantation
Manuscript Source	Invited Manuscript
All Author List	Shalom Z Frager, Weston Cooper, Yvonne Saenger and Jonathan M Schwartz
Funding Agency and Grant Number
Corresponding Author	Shalom Z Frager, MD, Staff Physician, Department of Hepatology , Montefiore Medical Center , 111 E 210th St, Bronx , NY 10467 , United States. shfrager@montefiore.org
Key Words	Hepatocellular carcinoma; HCC recurrence; Hepatic resection; Locoregional therapy; Immunotherapy
Core Tip	Tumor recurrence is frequent following potentially curative modalities for hepatocellular carcinoma. Patients should undergo surveillance imaging following curative treatments and once diagnosed, are potentially eligible for repeat hepatic resection, ablation, trans-arterial embolic therapies, or systemic therapies.
Publish Date	2023-02-02 09:33
Citation	Frager SZ, Cooper W, Saenger Y, Schwartz JM. Treatment of recurrent hepatocellular carcinoma following liver resection, ablation or liver transplantation. World J Meta-Anal 2023; 11(2): 47-54
URL	https://www.wjgnet.com/2308-3840/full/v11/i2/47.htm
DOI	https://dx.doi.org/10.13105/wjma.v11.i2.47

Full Article (PDF)	WJMA-11-47.pdf
Full Article (Word)	WJMA-11-47.docx
Manuscript File	80996_Auto_Edited-LM.docx
Answering Reviewers	80996-Answering reviewers.pdf
Audio Core Tip	80996-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	80996-Conflict-of-interest statement.pdf
Copyright License Agreement	80996-Copyright license agreement.pdf
Peer-review Report	80996-Peer-review(s).pdf
Scientific Misconduct Check	80996-Bing-Liu JH-2.jpg
Scientific Misconduct Check	80996-CrossCheck.jpg
Scientific Editor Work List	80996-Scientific editor work list.pdf
CrossCheck Report	80996-CrossCheck report.pdf